MIF-1 potentiates the action of tricyclic antidepressants in an animal model of depression
- 31 October 1991
- Vol. 12 (5) , 915-918
- https://doi.org/10.1016/0196-9781(91)90037-p
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbensJournal of Pharmacy and Pharmacology, 1988
- Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming testNeuropharmacology, 1987
- Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1Life Sciences, 1986
- Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugsPharmacology Biochemistry and Behavior, 1984
- Behavioral effects of melanocyte stimulating hormone release-inhibiting factor-1 (MIF-1)Neuroscience & Biobehavioral Reviews, 1983
- Are the pharmacological effects of L-prolyl-L-leucylglycinamide (PLG) mediated through specific receptor mechanisms?Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
- Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brainPharmacological Research Communications, 1983
- The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the ratLife Sciences, 1981
- Enkephalin and other peptides reduce passivenessPharmacology Biochemistry and Behavior, 1978
- DISTRIBUTION OF RADIOACTIVITY IN THE ORGANS OF THE RAT AND MOUSE AFTER INJECTION OF l-[3H]PROLYL-l-LEUCYL-GLYCINAMIDEJournal of Endocrinology, 1975